Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK

Journal of Immunology

Volumn 175, Issue 2, 2005, Pages 1197-1205

  Hagemann, Thorsten ^a   Wilson, Julia ^a   Kulbe, Hagen ^a   Li, Ningfeng Fiona ^a   Leinster, David A ^a   Charles, Kellie ^a   Klemm, Florian ^b   Pukrop, Tobias ^b   Binder, Claudia ^b   Balkwill, Frances R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; PROTEIN INHIBITOR; RNA INDUCED SILENCING COMPLEX; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CARCINOMA CELL; CELL IMMORTALIZATION; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

EID: 23244451640     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.2.1197     Document Type: Article

References (49)

1. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
2. Leek, R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56: 4625-4629.
3. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononudear phagocytes. Trends Immunol 23: 549-555.
4. Blankenstein, T., Z. H. Qin, K. Uberla, W. Muller, H. Rosen, H. D. Volk, and T. Diamantstein. 1991. Tumor suppression after tumor cell-targeted tumor necrosis factor α gene transfer. J. Exp. Med. 173: 1047-1052.
5. Bingle, L., N. J. Brown, and C. E. Lewis. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196: 254-265.
6. Torisu, H., M. Ono, H. Kiryu, M. Furue, Y. Ohmoto, J. Nakayama, Y. Nishioka, S. Sone, and M. Kuwano. 2000. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFα and IL-1α. Int. J. Cancer 85: 182-188.
7. Greten, F. R., L. Eckmann, T. F. Greten, J. M. Park, Z.-W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin. 2004. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
8. Pikarsky, E., R. M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah. 2004. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466.
9. Hagemann, T., S. C. Robinson, M. Schulz, L. Trumper, F. R. Balkwill, and C. Binder. 2004. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases. Carcinogenesis 25: 1543-1549.
10. Benard, J., J. Da Silva, M. C. De Blois, P. Boyer, P. Duvillard, E. Chiric, and G. Riou. 1985. Characterization of a human ovarian adenocarcinoma line. IGROV1, in tissue culture and in nude mice. Cancer Res. 45: 4970-4979.
11. Brummelkamp, T, R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
12. Graham, F. L., and A, J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467.
13. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
14. Dyer, R. B., and N. K. Herzog. 1995. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. BioTechniques 19: 192-195.
15. Lee, J. H., and C. J. Walsh. 1988. Transcriptional regulation of coordinate changes in flagellar mRNAs during differentiation of Naegleria gruberi amebae into flagellates. Mol. Cell. Biol 8: 2280-2287.
16. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
17. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
18. Robinson, S. C., K. A. Scott, and F. R. Balkwill. 2002. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α. Eur. J. Immunol. 32: 404-412.
19. Rozen, S., and H. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology. S. Krawetz and S. Misener. eds. Humana Press, Totowa, NJ, pp. 365-386.
20. Hagemann, T., B. Gunawan, M. Schulz, L. Fuzesi, and C. Binder. 2001. mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas. Eur. J. Cancer 37: 1839-1846.
21. Benotmane, A. M., M. F. Hoylaerts, D. Collen, and A. Belayew. 1997. Nonisotopic quantitative analysis of protein-DNA interactions at equilibrium. Anal. Biochem. 250: 181-185.
22. Shen, Z., J. Peedikayil, G. K. Olson, P. D. Siebert, and Y. Fang. 2002. Multiple transcription factor profiling by enzyme-linked immunoassay. BioTechniques 32: 1168-1174.
23. Sledz, C. A., M. Holko, M. J. de Veer, R. H. Silverman, and B. R. Williams. 2003. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5: 834-839.
24. Bridge, A. J., S. Pebernard, A. Ducraux, A. L. Nicoulaz, and R. Iggo. 2003. Induction of an interferon response by RNAi veciors in mammalian cells. Nat. Genet. 34: 263-264.
25. Tang, Y., P. Kesavan, M. T. Nakada, and L. Yan. 2004. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase- dependent generation of soluble EMMPRIN. Mol. Cancer Res. 2: 73-80.
26. Balkwill, F., and L. M. Coussens. 2004. Cancer: an inflammatory link. Nature 431: 405-406.
27. Szlosarek, P. W., and F. R. Balkwill. 2003. Tumour necrosis factor α: a potential target for the therapy of solid tumours. Lancet Oncol. 4: 565-573.
28. Moore, R. J., D. M. Owens, G. Stamp, C. Arnott, F. Burke, N. East, H. Holdsworth, L. Turner, B. Rollins, M. Pasparakis, et al. 1999. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med. 5: 828-831.
29. Balkwill, F. 2002. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13: 135-141.
30. Arnott, C, H., K. A. Scott, R. J. Moore, A. Hewer, D. H. Phillips, P. Parker, F. R. Balkwill, and D. M. Owens. 2002. Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway. Oncogene 21: 4728-4738.
31. Arnott, C. H., K. A. Scott, R. J. Moore, S. C. Robinson, R. G. Thompson, and F. R. Balkwill. 2004. Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development. Oncogene 23; 1902-1910.
32. Brenner, D. A., M. O'Hara, P. Angel, M. Chojkier, and M. Karin. 1989. Prolonged activation of jun and collagenase genes by tumour necrosis factor-α. Nature 337: 661-663.
33. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase sub-family of c-Jun kinases. Nature 369: 156-160.
34. Westwick, J. K., C. Weitzel, A. Minden, M. Karin, and D. A. Brenner. 1994. Tumor necrosis factor α stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269: 26396-26401.
35. Davis, R. J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.
36. Helbig, G., K. W. Christopherson. II. P. Bhat-Nakshatri, S. Kumar, H. Kishimoto, K. D. Miller, H. E. Broxmeyer, and H. Nakshatri. 2003. NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278: 21631-21638.
37. 2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell. Biol. 23: 2871-2882.
38. Eferl, R., R. Ricci, L. Kenner, R. Zenz, J. P. David, M. Rath, and E. F. Wagner. 2003. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112: 181-192.
39. Ehrhardt, H., S. Fulda, I. Schmid, J. Hiscott, K. M. Debatin, and I. Jeremias. 2003. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB. Oncogene 22: 3842-3852.
40. Kennedy, N. J., and R. J. Davis. 2003. Role of JNK in tumor development. Cell Cycle 2: 199-201.
41. Baud, V., and M. Karin. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11: 372-377.
42. Zhu, W., J. S. Downey, J. Gu, F. Di Padova, H. Gram, and J. Han. 2000. Regulation of TNF expression by multiple mitogen-activated protein kinase pathways. J. Immunol. 164: 6349-6358.
43. Wysk, M., D. D. Yang, H. T. Lu, R. A. Flavell, and R. J. Davis. 1999. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl. Acad. Sci. USA 96: 3763-3768.
44. Leber, T. M., and F. R. Balkwill. 1998. Regulation of monocyte MMP-9 production by TNF-α and a tumour-derived soluble factor (MMPSF). Br. J. Cancer 78: 724-732.
45. Boyd, R. S., and F. R. Balkwill. 1999. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br. J. Cancer 80: 315-321.
46. Suzuki, S., M. Saw, H. Senoo, and K. Ishikawa. 2004. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP. Exp. Cell Res. 293: 259-266.
47. Sidhu, S. S., A. T. Mengistab, A. N. Tauscher, J. LaVail, and C. Basbaum. 2004. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 23: 956-963.
48. Kanekura, T., X. Chen, and T. Kanzaki. 2002. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int. J. Cancer 99: 520-528.
49. Mitchell, R. A. 2004. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell. Signal. 16: 13-19.